Oryzon Genomics SA (ORY) — Working Capital to Net Assets Ratio
Oryzon Genomics SA (ORY) has a Working Capital to Net Assets ratio of 12.6% as of December 2025. Working capital of €14.90 Million (current assets of €30.67 Million minus current liabilities of €15.77 Million) is measured against net assets of €117.85 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Oryzon Genomics SA (ORY) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Oryzon Genomics SA Working Capital to Net Assets (2013–2025)
This chart shows how Oryzon Genomics SA's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 12.6%, reflecting working capital of €14.90 Million against net assets of €117.85 Million EUR. Check ORY intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Oryzon Genomics SA (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Oryzon Genomics SA from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Oryzon Genomics SA.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 12.6% | €14.90 Million | €117.85 Million | €30.67 Million | €15.77 Million | ▲ +16.1 pp |
| 2024 | -3.4% | €-2.99 Million | €87.04 Million | €8.75 Million | €11.74 Million | ▼ -0.8 pp |
| 2023 | -2.6% | €-2.14 Million | €81.77 Million | €14.28 Million | €16.41 Million | ▼ -11.5 pp |
| 2022 | 8.9% | €6.43 Million | €72.57 Million | €25.16 Million | €18.73 Million | ▼ -24.7 pp |
| 2021 | 33.6% | €23.93 Million | €71.26 Million | €32.61 Million | €8.67 Million | ▼ -12.1 pp |
| 2020 | 45.7% | €34.68 Million | €75.93 Million | €42.38 Million | €7.69 Million | ▲ +45.6 pp |
| 2019 | 0.1% | €62.17K | €80.02 Million | €141.56K | €79.38K | ▼ -55.8 pp |
| 2018 | 55.9% | €25.22 Million | €45.13 Million | €35.66 Million | €10.44 Million | ▼ -23.8 pp |
| 2017 | 79.7% | €27.43 Million | €34.43 Million | €36.13 Million | €8.70 Million | ▼ -12.2 pp |
| 2016 | 91.9% | €20.88 Million | €22.73 Million | €28.48 Million | €7.60 Million | ▲ +28.9 pp |
| 2015 | 63.0% | €17.38 Million | €27.59 Million | €22.68 Million | €5.30 Million | ▲ +19.6 pp |
| 2014 | 43.4% | €6.03 Million | €13.89 Million | €10.00 Million | €3.97 Million | ▲ +42.5 pp |
| 2013 | 0.9% | €127.14K | €14.73 Million | €2.85 Million | €2.72 Million | — |